The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Understanding Your Risk: What Are My Chances of Being Diagnosed with Gynecologic Cancer?
Bridging the Gap: Addressing Disparities in Ovarian Cancer Clinical Trial Participation
Common Analgesics and Ovarian Cancer Survival: The Ovarian Cancer Prognosis and Lifestyle
Processed Foods and Cancer
The Risks of Cancer in Older Women with BRCA Pathogenic Variants: How Far Have We Come?
Use of Straighteners and Other Hair Products and Incident Uterine Cancer
Frequent Aspirin Use and Ovarian Cancer Risk
Three Icons of Stage and Screen Lost to Ovarian Cancer
Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older
‘Drug factory’ Implants Eliminate Ovarian, Colorectal Cancer in Mice
Risk of Cancer after Premenopausal Bilateral Oophorectomy
Prevention of Ovarian Cancer
Liquid Biopsy in Ovarian Cancer
Risk of Peritoneal Cancer After Risk-Reducing Bilateral Salpingo-Oophorectomy for Women
Impact of Care by Gynecologic Oncologists on Primary Ovarian Cancer Survival: Population-based Study
Contraceptive Use and the Risk of Ovarian Cancer Among Women With a BRCA1 or BRCA2 Mutation
Ovarian Cancer Incidence and Death in Women Undergoing Bilateral Salpingo-Oophorectomy
When Ovarian Cancer Returns, Surgery May Be a Good Choice for Selected Patients
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Lighting the Way for Improved Detection of Ovarian Cancer
